Literature DB >> 9334939

Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material.

G Danscher1, K B Jensen, C J Frederickson, K Kemp, A Andreasen, S Juhl, M Stoltenberg, R Ravid.   

Abstract

Zinc has been implicated as a contributing cause of the neuropathology of Alzheimer's disease (AD), but consensus on the zinc content of AD brains has not yet been established. In the present study, multi-element PIXE was used to measure zinc in cryostat sections of brain tissue from AD patients and from normal control subjects. Compared to their age-matched controls, the AD patients showed an increase in zinc in the hippocampal and amygdalar regions. The instrumental PIXE assays do not show whether the zinc changes are due to altered zinc in the boutons of Zinc-ENriched (ZEN) neurons, i.e., zinc ions in synaptic vesicles, or to changes in the amount of zinc tightly bound to macromolecules. We hypothesise that the increased zinc level is caused by an increase in the amount of ZEN terminals. Such an increase could be the result of a sprout of ZEN terminals in diseased areas of the brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334939     DOI: 10.1016/s0165-0270(97)00079-4

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  41 in total

1.  Selective, quantitative measurement of releasable synaptic zinc in human autopsy hippocampal brain tissue from Alzheimer's disease patients.

Authors:  Nicole L Bjorklund; V-M Sadagoparamanujam; Giulio Taglialatela
Journal:  J Neurosci Methods       Date:  2011-09-16       Impact factor: 2.390

2.  Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.

Authors:  Steven T Szabo; G Jean Harry; Kathleen M Hayden; David T Szabo; Linda Birnbaum
Journal:  Toxicol Sci       Date:  2015-12-31       Impact factor: 4.849

3.  Zinc-dependent multi-conductance channel activity in mitochondria isolated from ischemic brain.

Authors:  Laura Bonanni; Mushtaque Chachar; Teresa Jover-Mengual; Hongmei Li; Adrienne Jones; Hidenori Yokota; Dimitry Ofengeim; Richard J Flannery; Takahiro Miyawaki; Chang-Hoon Cho; Brian M Polster; Marc Pypaert; J Marie Hardwick; Stefano L Sensi; R Suzanne Zukin; Elizabeth A Jonas
Journal:  J Neurosci       Date:  2006-06-21       Impact factor: 6.167

4.  Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer's disease brain.

Authors:  Ganna Lyubartseva; Jennifer L Smith; William R Markesbery; Mark A Lovell
Journal:  Brain Pathol       Date:  2009-04-07       Impact factor: 6.508

5.  Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion.

Authors:  Matthew Schrag; Claudius Mueller; Udochukwu Oyoyo; Mark A Smith; Wolff M Kirsch
Journal:  Prog Neurobiol       Date:  2011-05-11       Impact factor: 11.685

Review 6.  A potential role for zinc alterations in the pathogenesis of Alzheimer's disease.

Authors:  Ganna Lyubartseva; Mark A Lovell
Journal:  Biofactors       Date:  2012-03-23       Impact factor: 6.113

7.  Serum zinc in the progression of Alzheimer's disease.

Authors:  Jiang Dong; J David Robertson; William R Markesbery; Mark A Lovell
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

8.  The effect of cadmium on Aβ levels in APP/PS1 transgenic mice.

Authors:  Xiaoling Li; Yongli Lv; Song Yu; Haihua Zhao; Lijie Yao
Journal:  Exp Ther Med       Date:  2012-04-26       Impact factor: 2.447

Review 9.  A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease.

Authors:  Mark A Lovell
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain.

Authors:  Nancy Beyer; David Tr Coulson; Shirley Heggarty; Rivka Ravid; G Brent Irvine; Jan Hellemans; Janet A Johnston
Journal:  Mol Neurodegener       Date:  2009-12-23       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.